We checked the VEAL2 expression in the blood samples of DM (n = 50), non‐proliferative DR (NPDR) (n = 50), and proliferative DR (PDR) patients (n = 50) and compared them with VEAL2 levels in blood samples of control individuals (n = 50). This evidence concerns the gene MYADM-AS2 and diabetes mellitus.